Acta Med. 2000, 43: 75-82

https://doi.org/10.14712/18059694.2019.117

Anthracycline-Induced Cardiotoxicity

Radomír Hrdinaa, Vladimír Geršlb, Ivona Klimtováa, Tomáš Šimůneka, Jarmila Macháčkováb, Michaela Adamcovác

aCharles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmacology and Toxicology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Pharmacology, Hradec Králové, Czech Republic
cCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Physiology, Hradec Králové, Czech Republic

Received May 1, 2000
Accepted June 1, 2000

Crossref Cited-by Linking

  • Pozo Maria R., Meredith Gantt W., Entcheva Emilia: Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology. Cells 2022, 11, 200. <https://doi.org/10.3390/cells11020200>
  • Radić Jelena, Kolarov Bjelobrk, Stefanović Maja, Bosanac Milana, Cvetković Biljana, Janičić Stefan, Dolamić Borislav, Ćuk Dragomir, Andrejić-Višnjić Bojana: Cardiotoxicity of doxorubicin: Causes, diagnosis, consequences and possibilities of prevention. Hosp Pharm Int Multi J 2022, 9, 1143. <https://doi.org/10.5937/hpimj2201143R>
  • Naraki Karim, Rezaee Ramin, Mashayekhi‐Sardoo Habibeh, Hayes A. Wallace, Karimi Gholamreza: Mangiferin offers protection against deleterious effects of pharmaceuticals, heavy metals, and environmental chemicals. Phytotherapy Research 2021, 35, 810. <https://doi.org/10.1002/ptr.6864>
  • Choi Jong-Soo, Park Jae-Won, Seu Young-Bae, Doh Kyung-Oh: Enhanced efficacy of folate-incorporated cholesteryl doxorubicin liposome in folate receptor abundant cancer cell. Journal of Drug Delivery Science and Technology 2021, 62, 102385. <https://doi.org/10.1016/j.jddst.2021.102385>
  • Pitchakarn Pornsiri, Inthachat Woorawee, Karinchai Jirarat, Temviriyanukul Piya: Human Hazard Assessment Using Drosophila Wing Spot Test as an Alternative In Vivo Model for Genotoxicity Testing—A Review. IJMS 2021, 22, 9932. <https://doi.org/10.3390/ijms22189932>
  • Xu Jing, Liu Dandan, Xiao Shengxiang, Meng Xinxin, Zhao Di, Jiang Xin, Jiang Xue, Cai Lu, Jiang Hongyu: Low-Dose Radiation Prevents Chemotherapy-Induced Cardiotoxicity. Curr Stem Cell Rep 2019, 5, 82. <https://doi.org/10.1007/s40778-019-00158-x>
  • Shevchuk O. O.: ЕФЕКТИ ЕНТЕРОСОРБЦІЇ ТА ФІЛГРАСТИМУ ПРИ СУБХРОНІЧНІЙ ДОКСОРУБІЦИНОВІЙ ТОКСИЧНОСТІ. ЗКЕМ 2019, 146. <https://doi.org/10.11603/1811-2471.2019.v.i3.10510>
  • Jansová Hana, Šimůnek Tomáś: Cardioprotective Potential of Iron Chelators and Prochelators. CMC 2019, 26, 288. <https://doi.org/10.2174/0929867324666170920155439>
  • Khafaga Asmaa F., El-Sayed Yasser S.: All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression. Naunyn-Schmiedeberg's Arch Pharmacol 2018, 391, 59. <https://doi.org/10.1007/s00210-017-1437-5>
  • Imam Faisal, Al-Harbi Naif O., Al-Harbi Mohammad Matar, Ansari Mushtaq Ahmad, Al-Asmari Abdullah F, Ansari Mohd Nazam, Al-Anazi Wael A., Bahashwan Saleh, Almutairi Mashal M, Alshammari Musaad, Khan Mohammad Rashid, Alsaad Abdulaziz Mohammed, Alotaibi Moureq Rashed: Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways. Pharmacological Reports 2018, 70, 993. <https://doi.org/10.1016/j.pharep.2018.03.009>
  • Yu Jie, Wang Changxi, Kong Qi, Wu Xiaxia, Lu Jin-Jian, Chen Xiuping: Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products. Phytomedicine 2018, 40, 125. <https://doi.org/10.1016/j.phymed.2018.01.009>
  • Pecoraro Michela, Ciccarelli Michele, Fiordelisi Antonella, Iaccarino Guido, Pinto Aldo, Popolo Ada: Diazoxide Improves Mitochondrial Connexin 43 Expression in a Mouse Model of Doxorubicin-Induced Cardiotoxicity. IJMS 2018, 19, 757. <https://doi.org/10.3390/ijms19030757>
  • Coelho Ana R., Martins Tatiana R., Couto Renata, Deus Cláudia, Pereira Cláudia V., Simões Rui F., Rizvanov Albert A., Silva Filomena, Cunha-Oliveira Teresa, Oliveira Paulo J., Serafim Teresa L.: Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017, 1863, 2904. <https://doi.org/10.1016/j.bbadis.2017.07.030>
  • Xu Fan, Li Xiao, Liu Lanfang, Xiao Xu, Zhang Li, Zhang Shenglin, Lin Pingping, Wang Xiaojie, Wang Yongwei, Li Qingshan: Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression. Experimental and Therapeutic Medicine 2017, 14, 2216. <https://doi.org/10.3892/etm.2017.4763>
  • Jian Chun-Yan, Ouyang Han-Bin, Xiang Xian-Hong, Chen Jia-Li, Li Yong-Xin, Zhou Xin, Wang Jin-Yang, Yang Yang, Zhong En-Yi, Huang Wen-Hua, Zhang Hong-Wu: Naringin protects myocardial cells from doxorubicin-induced apoptosis partially by inhibiting the p38MAPK pathway. Molecular Medicine Reports 2017, 16, 9457. <https://doi.org/10.3892/mmr.2017.7823>
  • Chakraborty M, Bhattacharjee A., Kamath J. V.: CARDIOPROTECTIVE EFFECT OF URSOLIC ACID AGAINST DOXORUBICIN INDUCED CARDIOTOXICITY. IND. DRU. 2016, 53, 65. <https://doi.org/10.53879/id.53.11.10769>
  • Markman Timothy M., Markman Maurie: Cardiotoxicity of Antineoplastic Agents: What Is the Present and Future Role for Imaging?. Curr Oncol Rep 2014, 16. <https://doi.org/10.1007/s11912-014-0396-y>
  • Štěrba Martin, Popelová Olga, Vávrová Anna, Jirkovský Eduard, Kovaříková Petra, Geršl Vladimír, Šimůnek Tomáš: Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection. Antioxidants & Redox Signaling 2013, 18, 899. <https://doi.org/10.1089/ars.2012.4795>
  • Bains Onkar S., Szeitz András, Lubieniecka Joanna M., Cragg Gina E., Grigliatti Thomas A., Riggs K. Wayne, Reid Ronald E.: A Correlation between Cytotoxicity and Reductase-Mediated Metabolism in Cell Lines Treated with Doxorubicin and Daunorubicin. J Pharmacol Exp Ther 2013, 347, 375. <https://doi.org/10.1124/jpet.113.206805>
  • GUO RUN-MIN, XU WEN-MING, LIN JIAN-CONG, MO LI-QIU, HUA XIAO-XIAO, CHEN PEI-XI, WU KENG, ZHENG DONG-DAN, FENG JIAN-QIANG: Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Molecular Medicine Reports 2013, 8, 603. <https://doi.org/10.3892/mmr.2013.1554>
  • Wang Xiu-Yu, Yang Chun-Tao, Zheng Dong-Dan, Mo Li-Qiu, Lan Ai-Ping, Yang Zhan-Li, Hu Fen, Chen Pei-Xi, Liao Xin-Xue, Feng Jian-Qiang: Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress. Mol Cell Biochem 2012, 363, 419. <https://doi.org/10.1007/s11010-011-1194-6>
  • Zatloukalová Libuše, Filipský Tomáš, Mladěnka Přemysl, Semecký Vladimír, Macáková Kateřina, Holečková Magdalena, Vávrová Jaroslava, Palicka Vladimir, Hrdina Radomír: Dexrazoxane provided moderate protection in a catecholamine model of severe cardiotoxicity. Can. J. Physiol. Pharmacol. 2012, 90, 473. <https://doi.org/10.1139/y2012-009>
  • Oztarhan Kazım, Guler Serhat, Aktas Belgin, Arslan Meliha, Salcioglu Zafer, Aydogan Gonul: The Value of Echocardiography Versus Cardiac Troponin I levels in the Early Detection of Anthracycline Cardiotoxicity in Childhood Acute Leukemia: Prospective Evaluation of a 7-Year-Long Clinical Follow-up. Pediatric Hematology and Oncology 2011, 28, 380. <https://doi.org/10.3109/08880018.2011.563772>
  • Šimůnek Tomáš, Štěrba Martin, Popelová Olga, Adamcová Michaela, Hrdina Radomír, Geršl Vladimír: Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacological Reports 2009, 61, 154. <https://doi.org/10.1016/S1734-1140(09)70018-0>
  • Mladĕnka Pr̆emysl, Kalinowski Danuta S., Hašková Pavlína, Bobrovová Zuzana, Hrdina Radomír, Šimůnek Tomáš, Nachtigal Petr, Semecký Vladimír, Vávrová Jaroslava, Holečková Magdaléna, Palicka Vladimir, Mazurová Yvona, Jansson Patric J., Richardson Des R.: The Novel Iron Chelator, 2-Pyridylcarboxaldehyde 2-Thiophenecarboxyl Hydrazone, Reduces Catecholamine-Mediated Myocardial Toxicity. Chem. Res. Toxicol. 2009, 22, 208. <https://doi.org/10.1021/tx800331j>
  • Simunek Tomas, Sterba Martin, Popelova Olga, Kaiserova Helena, Potacova Anna, Adamcova Michaela, Mazurova Yvona, Ponka Premysl, Gersl Vladimir: Pyridoxal Isonicotinoyl Hydrazone (PIH) and its Analogs as Protectants Against Anthracycline-Induced Cardiotoxicity. Hemoglobin 2008, 32, 207. <https://doi.org/10.1080/03630260701680276>
  • Kaiserová Helena, Šimůnek Tomáš, Štěrba Martin, den Hartog Gertjan J. M., Schröterová Ladislava, Popelová Olga, Geršl Vladimír, Kvasničková Eva, Bast Aalt: New iron chelators in anthracycline-induced cardiotoxicity. Cardiovasc Toxicol 2007, 7, 145. <https://doi.org/10.1007/s12012-007-0020-6>
  • Kaiserová Helena, Šimůnek Tomáš, van der Vijgh Wim J.F., Bast Aalt, Kvasničková Eva: Flavonoids as protectors against doxorubicin cardiotoxicity: Role of iron chelation, antioxidant activity and inhibition of carbonyl reductase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2007, 1772, 1065. <https://doi.org/10.1016/j.bbadis.2007.05.002>
  • Adamcová Michaela, Šimůnek Tomáš, Kaiserová Helena, Popelová Olga, Štěrba Martin, Potáčová Anna, Vávrová Jaroslava, Maláková Jana, Geršl Vladimír: In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity. Toxicology 2007, 237, 218. <https://doi.org/10.1016/j.tox.2007.05.016>
  • Radulescu Dan, Pripon Sorin, Parv Andreea, Duncea Caius, Ciuleanu Tudor E., Radulescu Letitia I.: Altered Left Ventricular Diastolic Performance in Oncologic Patients Treated With Epirubicin. Congestive Heart Failure 2007, 13, 215. <https://doi.org/10.1111/j.1527-5299.2007.07122.x>
  • Potáčová Anna, Adamcová Michaela, Štěrba Martin, Popelová Olga, Šimůnek Tomáš, Mazurová Yvona, Gunčová Ivana, Geršl Vladimír: A Pilot Study of Matrix Metalloproteinases on the Model of Daunorubicin-induced Cardiomyopathy in Rabbits. Acta Med. (Hradec Kralove, Czech Repub.) 2007, 50, 109. <https://doi.org/10.14712/18059694.2017.65>
  • Štěrba Martin, Popelová Olga, Šimůnek Tomáš, Mazurová Yvona, Potáčová Anna, Adamcová Michaela, Kaiserová Helena, Poňka Přemysl, Geršl Vladimír: Cardioprotective Effects of a Novel Iron Chelator, Pyridoxal 2-Chlorobenzoyl Hydrazone, in the Rabbit Model of Daunorubicin-Induced Cardiotoxicity. J Pharmacol Exp Ther 2006, 319, 1336. <https://doi.org/10.1124/jpet.106.111468>
  • Šimůnek Tomáš, Štěrba Martin, Holečková Magdaléna, Kaplanová Jana, Klimtová Ivona, Adamcová Michaela, Geršl Vladimír, Hrdina Radomír: Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits. Biometals 2005, 18, 163. <https://doi.org/10.1007/s10534-004-4491-7>
  • Ascensão António, Magalhães José, Soares José, Ferreira Rita, Neuparth Maria, Marques Franklim, Oliveira José, Duarte José: Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. International Journal of Cardiology 2005, 100, 451. <https://doi.org/10.1016/j.ijcard.2004.11.004>
  • Ravi Dashnamoorthy, Muniyappa Harish, Das Kumuda C.: Endogenous Thioredoxin Is Required for Redox Cycling of Anthracyclines and p53-dependent Apoptosis in Cancer Cells. Journal of Biological Chemistry 2005, 280, 40084. <https://doi.org/10.1074/jbc.M507192200>
  • Adamcová Michaela, Šterba Martin, Šimunek Tomáš, Potácová Anna, Popelová Olga, Mazurová Yvona, Geršl Vladimír: Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity. Expert Opinion on Drug Safety 2005, 4, 457. <https://doi.org/10.1517/14740338.4.3.457>
  • Ravi Dashnamoorthy, Das Kumuda C.: Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage. Cancer Chemother Pharmacol 2004, 54, 449. <https://doi.org/10.1007/s00280-004-0833-y>
  • Šimůnek Tomáš, Klimtová Ivona, Kaplanová Jana, Mazurová Yvona, Adamcová Michaela, Štěrba Martin, Hrdina Radomír, Geršl Vladimír: Rabbit model for in vivo study of anthracycline‐induced heart failure and for the evaluation of protective agents. European J of Heart Fail 2004, 6, 377. <https://doi.org/10.1016/j.ejheart.2003.05.003>
Crossref Cited-by Linking logo